Advertisement
Research ArticleViewpoint

Brightening the Path: Riboflavin Illuminates Breast Cancer Resistance Protein Monitoring

Marta Melis
Journal of Pharmacology and Experimental Therapeutics August 2024, 390 (2) 159-161; DOI: https://doi.org/10.1124/jpet.124.002155

Article Information

vol. 390 no. 2 159-161
DOI 
https://doi.org/10.1124/jpet.124.002155
PubMed 
39025655
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received February 5, 2024
  • Accepted February 27, 2024
  • Published online July 18, 2024.
Copyright & Usage 
Copyright © 2024 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Marta Melis
  1. Address correspondence to:
    Dr. Marta Melis, Assistant Professor, Department of Pharmacology, Weill Cornell Medicine, 1300 York Avenue, New York, NY 10065. E-mail: mam2185{at}med.cornell.edu

Statistics from Altmetric.com

Article usage

Article usage: July 2024 to December 2024

AbstractFullPdf
Jul 20240594112
Aug 2024050877
Sep 202405521
Oct 20240289
Nov 20240215
Dec 20240136

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleViewpoint

Riboflavin As a BCRP Biomarker

Marta Melis
Journal of Pharmacology and Experimental Therapeutics August 1, 2024, 390 (2) 159-161; DOI: https://doi.org/10.1124/jpet.124.002155
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement